°£¾Ï¿¡¼ ÁÁÀº °á°ú¸¦ ¿¹»óÇϰí Ä¡·á¸¦(TACE, RFA, OP/LT, Cyber knife µî) ÇÏ¿´À¸³ª Á¶±â Àç¹ßÇÑ °£¾Ï Áõ·Ê : Milan±âÁØ¿¡ ÇÕ´çÇÑ °£¾Ï¿¡¼ °£ÀÌ½Ä ÈÄ Àç¹ß 1¿¹
Rapid recurrence following Living donor Liver transplantation for hepatocellular carcinoma within Milan criteria
¿ìÇö¿µ, ±ÇÁ¤Çö, ±èµ¿±¸, À¯¿µ°æ, ¹è½ÃÇö, ³ª¼ºÀº, º¯À翵, À±½Â±Ô, ÃÖº´±æ, ±èÁøµ¿, ÃÖÁ¾¿µ, ÀÌÇØ±Ô, õȣÁ¾,
¼Ò¼Ó »ó¼¼Á¤º¸
¿ìÇö¿µ ( Woo Hyun-Young ) - µ¿¾Æ´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
±ÇÁ¤Çö ( Kwon Jung-Hyun ) - °¡Å縯´ëÇб³ Àǰú´ëÇÐ °³²¼º¸ðº´¿ø ³»°ú
±èµ¿±¸ ( Kim Dong-Goo ) - °¡Å縯´ëÇб³ Àǰú´ëÇÐ ¿Ü°úÇб³½Ç
À¯¿µ°æ ( You Young-Kyoung ) - °¡Å縯´ëÇб³ Àǰú´ëÇÐ °³²¼º¸ðº´¿ø ¿Ü°ú
¹è½ÃÇö ( Bae Si-Hyun ) - °¡Å縯ÀÇ´ë ³»°ú
³ª¼ºÀº ( Rha Sung-Eun ) - °¡Å縯´ëÇб³ Àǰú´ëÇÐ °³²¼º¸ðº´¿ø ¿µ»óÀÇÇаú
º¯À翵 ( Byun Jae-Young ) - °¡Å縯´ëÇб³ Àǰú´ëÇÐ °³²¼º¸ðº´¿ø ¿µ»óÀÇÇаú
À±½Â±Ô ( Yoon Seung-Kew ) - °¡Å縯´ëÇб³ Àǰú´ëÇÐ ¼º¸ðº´¿ø ¼Òȱ⳻°úÇб³½Ç
ÃÖº´±æ ( Choi Byung-Gil ) - °¡Å縯´ëÇб³ °³²¼º¸ðº´¿ø ¿µ»óÀÇÇаú
±èÁøµ¿ ( Kim Jin-Dong ) - °¡Å縯´ëÇб³ Àǰú´ëÇÐ ¼¿ï¼º¸ðº´¿ø ¼Òȱ⳻°ú
ÃÖÁ¾¿µ ( Choi Jong-Young ) - °¡Å縯´ëÇб³ Àǰú´ëÇÐ ¼¿ï¼º¸ðº´¿ø ¼Òȱ⳻°ú
ÀÌÇØ±Ô ( Lee Hae-Giu ) - °¡Å縯´ëÇб³ Àǰú´ëÇÐ ¿µ»óÀÇÇб³½Ç
õȣÁ¾ ( Chun Ho-Jong ) - °¡Å縯´ëÇб³ Àǰú´ëÇÐ ¿µ»óÀÇÇаú
KMID : 0964020090090010045
Abstract
Liver transplantation is curative therapy for hepatocellular carcinoma especially if ,within Milan criteria, 4 year survival
and recurrence-free survival was reported to be 85% and 92%, respectively. Herein we report a patient who experience rapid recurrence following living donor liver transplantation (LDLT) for hepatocellular carcinoma within Milan criteria. A 52 year-old-men patient with known liver cirrhosis associated with hepatitis B virus was admitted for the treatment of
hepatocellular carcinoma (HCC). Abdominal CT revealed two nodules less than 3 cm in right hepatic lobe. After single
session of transcatheter arterial chemoembolization (TACE), the patient underwent LDLT. After seven months following
transplantation, recurrent HCC was detected on transplanted liver with concurrent metastatic nodule in lung. Although TACE and metastsectomy were performed for recurrent intrahepatic mass and lung metastasis, recurrent HCC showed rapid progression and patient died of progressive tumor after 10 months following LDLT.
Ű¿öµå
Hepatocellular carcinoma;Recurrence;Liver transplantation;Milan criteria
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸